Concepedia

Paul Gillard

PG

30

Publications

5.3K

Citations

21

H-Index

2006

Active since

Affiliations

GlaxoSmithKline (Belgium)(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (India)

Taipei Veterans General Hospital

Paul Gillard is an author at GlaxoSmithKline (Belgium) specializing in medicine, vaccination, and vaccine safety.

ORCID

Top concepts

Publications per year

2006–2021

30

Publications

30

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

Guillermo M. Ruiz‐Palacios, Irene Pérez‐Schael, F. Raúl Velázquez et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

Shabir A. Madhi, Nigel A. Cunliffe, A. Duncan Steele et al. · New England Journal of Medicine · 2010 · 906 citations · Full text

Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Dereck Tait, Mark Hatherill, Olivier Van Der Meeren et al. · New England Journal of Medicine · 2019 · 561 citations · Full text

Phase 2b Controlled Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba et al. · New England Journal of Medicine · 2018 · 392 citations · Full text

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

Alexandre C. Linhares, F. Raúl Velázquez, Irene Pérez‐Schael et al. · The Lancet · 2008 · 379 citations

, , +8

Rows per page

1–5 of 30